-
1
-
-
12244253742
-
Antifungal activity of the echinocandin Anidulafungin (VER002-6, LY-303366) against yeast pathogens: A comparative study with M27-A microdilution method
-
Arévalo MP, Carrillo-Muñoz AJ, Salgado J, Cárdenes D, Brió S, Estivill D, Quindós G, Espinel-Ingroff A. Antifungal activity of the echinocandin Anidulafungin (VER002-6, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method. J Antimicrob Chemother 2003; 51: 163-166.
-
(2003)
J Antimicrob Chemother
, vol.51
, pp. 163-166
-
-
Arévalo, M.P.1
Carrillo-Muñoz, A.J.2
Salgado, J.3
Cárdenes, D.4
Brió, S.5
Estivill, D.6
Quindós, G.7
Espinel-Ingroff, A.8
-
2
-
-
0036840519
-
In vitro activity of caspofungin against Candida albicans biofilms
-
Bachmann SP, Vandewalle K, Ramage G, Patterson T, Wickes BL, Graybill JR, López-Ribot JL. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002; 46: 3591-3596.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 3591-3596
-
-
Bachmann, S.P.1
Vandewalle, K.2
Ramage, G.3
Patterson, T.4
Wickes, B.L.5
Graybill, J.R.6
López-Ribot, J.L.7
-
3
-
-
0037347350
-
Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species
-
Cantón E, Pemán J, Viudes A, Quindós G, Gobernado M, Espinel-Ingroff A. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagnostic Microbiol Infect Dis 2003; 45: 203-206.
-
(2003)
Diagnostic Microbiol Infect Dis
, vol.45
, pp. 203-206
-
-
Cantón, E.1
Pemán, J.2
Viudes, A.3
Quindós, G.4
Gobernado, M.5
Espinel-Ingroff, A.6
-
4
-
-
0034870709
-
Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance
-
Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-5394.
-
(2001)
J Bacteriol
, vol.183
, pp. 5385-5394
-
-
Chandra, J.1
Kuhn, D.M.2
Mukherjee, P.K.3
Hoyer, L.L.4
McCormick, T.5
Ghannoum, M.A.6
-
5
-
-
33846014067
-
Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard
-
Clinical and Laboratory Standards Institute, 2 nd ed, Wayne, PA
-
nd ed. CLSI document M27-A2. Wayne, PA, 2002.
-
(2002)
CLSI document
-
-
-
6
-
-
24644448753
-
Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms
-
Cocuaud C, Rodier M-H, Daniault G, Imbert C. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 2005; 56: 507-512.
-
(2005)
J Antimicrob Chemother
, vol.56
, pp. 507-512
-
-
Cocuaud, C.1
Rodier, M.-H.2
Daniault, G.3
Imbert, C.4
-
7
-
-
33750577895
-
In vitro Pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility
-
Cota J, Carden M, Graybill JR, Najvar LK, Burgess DS, Wiederhold NP. In vitro Pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrob Agents Chemother 2006; 50: 3926-3928.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 3926-3928
-
-
Cota, J.1
Carden, M.2
Graybill, J.R.3
Najvar, L.K.4
Burgess, D.S.5
Wiederhold, N.P.6
-
8
-
-
0033591467
-
Bacterial biofilms: A common cause of persistent infections
-
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999; 284: 1318-1322.
-
(1999)
Science
, vol.284
, pp. 1318-1322
-
-
Costerton, J.W.1
Stewart, P.S.2
Greenberg, E.P.3
-
9
-
-
0032502811
-
The involvement of cell-to-cell Signals in the development of a bacterial biofilm
-
Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell Signals in the development of a bacterial biofilm. Science 1998; 280: 294-298.
-
(1998)
Science
, vol.280
, pp. 294-298
-
-
Davies, D.G.1
Parsek, M.R.2
Pearson, J.P.3
Iglewski, B.H.4
Costerton, J.W.5
Greenberg, E.P.6
-
10
-
-
0035887796
-
Biofilm formation: A clinically relevant microbiological process
-
Donlan RM. Biofilm formation: A clinically relevant microbiological process. Clin Infect Dis 2001; 33: 1387-1392.
-
(2001)
Clin Infect Dis
, vol.33
, pp. 1387-1392
-
-
Donlan, R.M.1
-
11
-
-
0036228505
-
Biofilms: Survival mechanisms of clinically relevant microorganisms
-
Donlan RM, Costerton W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
-
(2002)
Clin Microbiol Rev
, vol.15
, pp. 167-193
-
-
Donlan, R.M.1
Costerton, W.2
-
12
-
-
0036711963
-
Biofilms: Microbial life on surfaces
-
Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002; 8: 881-890.
-
(2002)
Emerg Infect Dis
, vol.8
, pp. 881-890
-
-
Donlan, R.M.1
-
13
-
-
0036756090
-
Medical importance of biofilms in Candida infections
-
Douglas LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol 2002; 19: 139-143.
-
(2002)
Rev Iberoam Micol
, vol.19
, pp. 139-143
-
-
Douglas, L.J.1
-
14
-
-
38349104634
-
Activity of micafungin against clinical isolates of Candida spp. and Candida albicans biofilms
-
París
-
Eraso E, Albaina O, Arechavala A, Sahand I, Carrillo-Muñoz A, Pontón J, Quindós G. Activity of micafungin against clinical isolates of Candida spp. and Candida albicans biofilms. The 16th Congress of the Internacional Society for Human and Animal Mycology. París, 2006. P-0069.
-
(2006)
The 16th Congress of the Internacional Society for Human and Animal Mycology
-
-
Eraso, E.1
Albaina, O.2
Arechavala, A.3
Sahand, I.4
Carrillo-Muñoz, A.5
Pontón, J.6
Quindós, G.7
-
16
-
-
0027976646
-
Biofilm formation by Candida species on the surface of catheter materials in vitro
-
Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Inmun 1994; 62: 915-821.
-
(1994)
Infect. Inmun
, vol.62
, pp. 915-821
-
-
Hawser, S.P.1
Douglas, L.J.2
-
17
-
-
0029135076
-
Resistance of Candida albicans biofilms to antifungal agents in vitro
-
Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995; 39: 2128-2131.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 2128-2131
-
-
Hawser, S.P.1
Douglas, L.J.2
-
18
-
-
0031980747
-
Comparison of a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(Phenyl-amino) carboxyl]-2 H-tetrazolium hydroxide (XTT) colorimetric mehod with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents
-
Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(Phenyl-amino) carboxyl]-2 H-tetrazolium hydroxide (XTT) colorimetric mehod with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450-1452.
-
(1998)
J Clin Microbiol
, vol.36
, pp. 1450-1452
-
-
Hawser, S.P.1
Norris, H.2
Jessup, C.J.3
Ghannoum, M.A.4
-
19
-
-
0038168441
-
Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection
-
Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003; 41: 2961-2967.
-
(2003)
J Clin Microbiol
, vol.41
, pp. 2961-2967
-
-
Jin, Y.1
Yip, H.K.2
Samaranayake, Y.H.3
Yau, J.Y.4
Samaranayake, L.P.5
-
20
-
-
85088684979
-
-
th International Congress of Chemotherapy (ICC). Munich, 2007.
-
th International Congress of Chemotherapy (ICC). Munich, 2007.
-
-
-
-
22
-
-
0036151240
-
Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces
-
Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Inmun 2002; 70: 878-888.
-
(2002)
Infect Inmun
, vol.70
, pp. 878-888
-
-
Kuhn, D.M.1
Chandra, J.2
Mukherjee, P.K.3
Ghannoum, M.A.4
-
23
-
-
0036096359
-
Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins
-
Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-1780.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 1773-1780
-
-
Kuhn, D.M.1
Chandra, J.2
Mukherjee, P.K.3
Ghannoum, M.A.4
-
24
-
-
27144503650
-
Alternative Candida albicans lifestyles: Growth on surfaces
-
Kumamoto CA, Vinces MD. Alternative Candida albicans lifestyles: growth on surfaces. Annu Rev Microbiol 2005; 59: 113-133.
-
(2005)
Annu Rev Microbiol
, vol.59
, pp. 113-133
-
-
Kumamoto, C.A.1
Vinces, M.D.2
-
25
-
-
0041764578
-
Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols
-
Mukherjee RK, Chandra J, Kuhn D.M, Ghannoum M.A. Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols. Infect Inmun 2003; 71: 4333-4340.
-
(2003)
Infect Inmun
, vol.71
, pp. 4333-4340
-
-
Mukherjee, R.K.1
Chandra, J.2
Kuhn, D.M.3
Ghannoum, M.A.4
-
26
-
-
10744224705
-
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States
-
Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, Horowitz HW, Powderly WG, Hyslop N, Kauffman CA, Cleary J, Mangino JE, Lee J. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother 2003; 47: 3149-3154.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 3149-3154
-
-
Ostrosky-Zeichner, L.1
Rex, J.H.2
Pappas, P.G.3
Hamill, R.J.4
Larsen, R.A.5
Horowitz, H.W.6
Powderly, W.G.7
Hyslop, N.8
Kauffman, C.A.9
Cleary, J.10
Mangino, J.E.11
Lee, J.12
-
27
-
-
0037407952
-
To build a biofilm
-
O'Toole GA. To build a biofilm. J Bacteriol 2003; 185: 2687-2689.
-
(2003)
J Bacteriol
, vol.185
, pp. 2687-2689
-
-
O'Toole, G.A.1
-
29
-
-
0242523776
-
Bacterial biofilms: An emerging link to disease pathogenesis
-
Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
-
(2003)
Annu Rev Microbiol
, vol.57
, pp. 677-701
-
-
Parsek, M.R.1
Singh, P.K.2
-
30
-
-
0035431077
-
Biofilms of Candida albicans and their associated resistance to antifungal agents
-
Ramage G, Wickes BL, López-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 2001; 20: 42-44.
-
(2001)
Am Clin Lab
, vol.20
, pp. 42-44
-
-
Ramage, G.1
Wickes, B.L.2
López-Ribot, J.L.3
-
32
-
-
0034863427
-
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
-
Ramage G, VandeWalle K, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-2479.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 2475-2479
-
-
Ramage, G.1
VandeWalle, K.2
Wickes, B.L.3
López-Ribot, J.L.4
-
33
-
-
0035992139
-
Investigation of multidrug efflux pumps in relation to fluconazol resistance in Candida albicans biofilms
-
Ramage G, Bachmann S, Patterson TF, Wickes BJ, López-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazol resistance in Candida albicans biofilms. J Antimicrob Chemoter 2002; 49: 973-980.
-
(2002)
J Antimicrob Chemoter
, vol.49
, pp. 973-980
-
-
Ramage, G.1
Bachmann, S.2
Patterson, T.F.3
Wickes, B.J.4
López-Ribot, J.L.5
-
34
-
-
0036840116
-
Inhibition of Candida albicans by farnesol, a quorum-sensing molecule
-
Ramage G, Saville S.P, Wickes BL, López-Ribot JL. Inhibition of Candida albicans by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002; 68: 5459-5463.
-
(2002)
Appl Environ Microbiol
, vol.68
, pp. 5459-5463
-
-
Ramage, G.1
Saville, S.P.2
Wickes, B.L.3
López-Ribot, J.L.4
-
38
-
-
33751182110
-
In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections
-
Seidler M, Salvenmoser S, Müller F-MC. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Agents 2006; 28: 568-573.
-
(2006)
Int J Antimicrob Agents
, vol.28
, pp. 568-573
-
-
Seidler, M.1
Salvenmoser, S.2
Müller, F.-M.C.3
-
39
-
-
33748035709
-
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model
-
Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis 2006; 194: 710-713.
-
(2006)
J Infect Dis
, vol.194
, pp. 710-713
-
-
Shuford, J.A.1
Rouse, M.S.2
Piper, K.E.3
Steckelberg, J.M.4
Patel, R.5
-
40
-
-
33847255390
-
In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile cells and planktonic clinical isolates
-
Shuford JA, Piper KE, Steckelberg JM, Patel R. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile cells and planktonic clinical isolates. Diag Microbiol Infect Dis 2007; 57: 277-281.
-
(2007)
Diag Microbiol Infect Dis
, vol.57
, pp. 277-281
-
-
Shuford, J.A.1
Piper, K.E.2
Steckelberg, J.M.3
Patel, R.4
-
42
-
-
0026647746
-
Innovative endpoint determination system for antifungal susceptibility testing of yeasts
-
Tellier R, Krajden M, Grigoriew A, Campbell I. Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob Agents Chemother 1992; 36: 1619-1625.
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 1619-1625
-
-
Tellier, R.1
Krajden, M.2
Grigoriew, A.3
Campbell, I.4
-
43
-
-
27144450690
-
The European Confederation of Medical Mycology (ECMN) survey of candidaemia in Italy: In vitro susceptibility of 375 Candida albicans isolates and biofilm production
-
Tortorano AM, Prigitano A, Biraghi E, Viviani MA. The European Confederation of Medical Mycology (ECMN) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production. J Antimicrob Chemother 2005; 56: 777-779.
-
(2005)
J Antimicrob Chemother
, vol.56
, pp. 777-779
-
-
Tortorano, A.M.1
Prigitano, A.2
Biraghi, E.3
Viviani, M.A.4
-
44
-
-
85088684332
-
-
th International Congress of Chemotherapy (ICC), Munich, 2007.
-
th International Congress of Chemotherapy (ICC), Munich, 2007.
-
-
-
-
45
-
-
33947648925
-
Anidulafungin - state of affairs from a clinical perspective
-
Vehreschild JJ, Kümmerle T, Karthaus M, Cornely OA. Anidulafungin - state of affairs from a clinical perspective. Mycoses 2007; 50(Supl. 1): 38-43.
-
(2007)
Mycoses
, vol.50
, Issue.SUPL. 1
, pp. 38-43
-
-
Vehreschild, J.J.1
Kümmerle, T.2
Karthaus, M.3
Cornely, O.A.4
|